Associated Papers
Diverse cell types establish a pathogenic immune environment in peripheral neuropathy.
Choi J et al.
Journal of Neuroinflammation, 2025
Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons.
Antoniou C et al.
Molecular Neurobiology, 2025
Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury.
Dogan EO et al.
Acta Neuropathologica Communications, 2023
Macrophage depletion blocks congenital SARM1-dependent neuropathy.
Dingwall CB et al.
The Journal of Clinical Investigation, 2022
Beyond diagnostic yield: prenatal exome sequencing results in maternal, neonatal, and familial clinical management changes.
Tolusso LK et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021
Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
Lukacs M et al.
Experimental Neurology, 2019
Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases.
Farwell Hagman KD et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017
Select a paper to view details